Correction: Exploring a New Entity of Single-Agent Pembrolizumab-Associated Hypophysitis.

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Mar 2024
Historique:
medline: 22 3 2024
pubmed: 22 3 2024
entrez: 22 3 2024
Statut: epublish

Résumé

[This corrects the article DOI: 10.7759/cureus.27763.].

Identifiants

DOI: 10.7759/cureus.c166 PMID: 38516288 PMC: PMC10955672
pubmed: 38516288
doi: 10.7759/cureus.c166
pmc: PMC10955672
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

c166

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2024, Balti et al.

Déclaration de conflit d'intérêts

No competing interests declared.

Auteurs

Eric Balti (E)

Department of Endocrinology and Diabetes, VITAZ Hospital, Sint-Niklaas, BEL.

Sarah Verhaeghe (S)

Department of Endocrinology and Diabetes, VITAZ Hospital, Sint-Niklaas, BEL.

Vibeke Kruse (V)

Department of Medical Oncology, VITAZ Hospital, Sint-Niklaas, BEL.
Department of Molecular Imaging, Pathology, Radiotherapy and Oncology (MIPRO), University of Antwerp, Wilrijk, BEL.
Department of Oncology, Antwerp University Hospital, Edegem, BEL.

Stijn Roels (S)

Department of Radiology, VITAZ Hospital, Sint-Niklaas, BEL.

Peter Coremans (P)

Department of Endocrinology and Diabetes, VITAZ Hospital, Sint-Niklaas, BEL.

Classifications MeSH